Please provide your email address to receive an email when new articles are posted on . Rates of overprescribing of short-acting beta agonist asthma inhalers remain high and vary significantly among ...

Researchers have found that more than a quarter of asthma patients are still over-using inhalers intended for rapid relief of symptoms. Overuse of these inhalers is linked to an increased risk of ...

An asthma rescue inhaler from partners AstraZeneca and Avillion has won FDA approval, giving patients the option of a single product that both manages symptoms and controls underlying inflammation.

Starting Saturday, the cost of inhalers will fall for many Americans, as new out-of-pocket price caps go into effect for the asthma medications from AstraZeneca and Boehringer Ingelheim. Following ...

Teva Respiratory, an affiliate of Teva Pharmaceutical Industries, completed its digital inhaler portfolio today with the launch of two new products: the AirDuo Digihaler and the ArmonAir Digihaler.

Summer temperatures, humidity and allergies are triggers for people diagnosed with asthma. These triggers can range from being a nuisance to being life-threatening. Dr. Jacqueline Squire, a Mayo ...

Early fall is when asthma flare-ups peak in the U.S., and a warming climate is bad news for sufferers: It means more ground-level ozone, a longer pollen season and more wildfire smoke – -all triggers ...